February 17, 2026

Janux Therapeutics, Inc. (JANX) Investor Outlook: A Potential 383.93% Upside in the Biotech Sector

Janux Therapeutics, Inc. (NASDAQ: JANX), a burgeoning name in the biotechnology industry, has captured investor attention with its cutting-edge immunotherapy platforms and a notably high potential..

Harrow, Inc. (HROW) Stock Analysis: A 48% Potential Upside in the Eye-Care Pharma Sector

Harrow, Inc. (NASDAQ: HROW), a prominent player in the healthcare sector, specializes in the development of ophthalmic pharmaceutical products. Headquartered in Nashville, Tennessee, this company has..

SS Innovations International (SSII) Stock Analysis: Exploring a Potential Growth Story in Surgical Robotics

SS Innovations International Inc. (SSII), a prominent player in the healthcare sector specializing in medical devices, is making waves in the surgical robotics industry. With a..

Kestra Medical Technologies (KMTS) Stock Analysis: Exploring 53.4% Revenue Growth and a 7.73% Upside Potential

Kestra Medical Technologies, Ltd. (KMTS), a notable player in the healthcare sector, is making waves in the medical instruments and supplies industry. Focused on enhancing cardiovascular..

LeMaitre Vascular, Inc. (LMAT) Investor Outlook: Exploring an 18% Potential Upside in the Medical Devices Sector

LeMaitre Vascular, Inc. (NASDAQ: LMAT) presents an intriguing opportunity for investors interested in the healthcare sector, particularly within the medical instruments and supplies industry. Based in..

Healthcare Services Group, Inc. (HCSG) Stock Analysis: 13.48% Potential Upside Attracts Investors

Healthcare Services Group, Inc. (NASDAQ: HCSG) is drawing attention from investors with its intriguing potential upside of 13.48%, as analysts set an average target price of..

Progyny, Inc. (PGNY) Stock Analysis: Discovering a 49.39% Potential Upside in the Healthcare Sector

Progyny, Inc. (NASDAQ: PGNY) has been making waves in the healthcare sector, particularly within the niche of fertility and women’s health benefits solutions. With a market..

Viridian Therapeutics, Inc. (VRDN) Stock Analysis: A 50.75% Upside Potential in Biotech

Viridian Therapeutics, Inc. (NASDAQ: VRDN) has garnered attention in the biotech sector, particularly for individual investors seeking high-growth opportunities. With a market capitalization of $2.66 billion,..

Acadia Healthcare (ACHC) Stock Analysis: Exploring the 13.72% Potential Upside

Acadia Healthcare Company, Inc. (ACHC), a key player in the healthcare sector, specializes in providing essential behavioral healthcare services across the United States and Puerto Rico...

Dynavax Technologies (DVAX) Stock Analysis: Exploring the 3.23% Upside Potential in the Burgeoning Vaccine Market

Dynavax Technologies Corporation (NASDAQ: DVAX), a key player in the biopharmaceutical sector, is making waves with its focus on developing and commercializing innovative vaccines. With a..

Ocular Therapeutix, Inc. (OCUL) Stock Analysis: Exploring a 188% Potential Upside with Strong Buy Ratings

For investors with an eye on biotech, Ocular Therapeutix, Inc. (NASDAQ: OCUL) presents an intriguing opportunity. Specializing in innovative therapies for retinal diseases and other eye..

Establishment Labs Holdings Inc (ESTA) Stock Analysis: Strong Revenue Growth and Potential Upside in Medical Devices

Establishment Labs Holdings Inc (NASDAQ: ESTA) is making waves in the healthcare sector, specifically within the medical devices industry. Known for its innovative approach to aesthetic..

Immunovant, Inc. (IMVT) Stock Analysis: A Biotech Play with 57.77% Potential Upside

Immunovant, Inc. (NASDAQ: IMVT) is attracting considerable attention in the investment community, particularly among those with an eye for high-reward opportunities in the biotechnology sector. With..

Merus N.V. (MRUS) Stock Analysis: Biotechnology Gem with 7.78% Potential Upside

Merus N.V. (NASDAQ: MRUS), a Netherlands-based biotechnology firm, stands at a pivotal point in its growth trajectory. Specializing in the development of innovative antibody therapeutics, Merus..

MannKind Corporation (MNKD) Stock Analysis: Exploring a 69.81% Potential Upside

MannKind Corporation (NASDAQ: MNKD), a key player in the biotechnology sector, is garnering significant attention from investors, thanks to its promising pipeline and substantial growth potential...

Perrigo Company plc (PRGO): Valuation Insights Reveal Significant 44% Upside Potential for Investors

Perrigo Company plc (NYSE: PRGO), a key player in the healthcare sector, stands out in the drug manufacturing industry with its focus on over-the-counter health and..

Disc Medicine, Inc. (IRON) Stock Report: Analyst Consensus Predicts 84.84% Upside Potential

Disc Medicine, Inc. (NASDAQ: IRON), a clinical-stage biopharmaceutical company, is gaining attention in the healthcare sector for its innovative focus on hematologic diseases. Headquartered in Watertown,..

NeoGenomics, Inc. (NEO) Investor Outlook: Assessing the 27.97% Potential Upside

NeoGenomics, Inc. (NASDAQ: NEO) stands as a noteworthy contender within the healthcare sector, specifically in the diagnostics and research industry. With a current market capitalization of..

ANI Pharmaceuticals (ANIP) Stock Analysis: Exploring a 42.84% Upside Potential

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) emerges as a compelling opportunity within the healthcare sector, particularly in the high-demand sphere of specialty and generic drug manufacturing. With..

Pediatrix Medical Group (MD) Stock Analysis: Exploring Growth Potential and Market Position

Pediatrix Medical Group, Inc. (NYSE: MD), a key player in the medical care facilities industry, holds a distinctive position within the healthcare sector. With a market..

Search

Funds

February 17, 2026

Search

Funds

February 17, 2026

FTSE 100

Funds